Semaglutide vs Liraglutide
Two GLP-1 agonists from the same family, separated mainly by half-life.
The short answer: Semaglutide persists for about a week; liraglutide for about half a day.
Semaglutide
Compound in Ozempic® · Wegovy®Liraglutide
Compound in Saxenda® · Victoza®Side by side
| Property | Semaglutide | Liraglutide |
|---|---|---|
| Research category | Metabolic Research | Metabolic Research |
| Presentation | 0.25mg × 4 pens | 0.6mg × 5 pens |
| Dosage options | 0.25mg × 4 pens · 1mg × 4 pens · 2.4mg × 4 pens | 0.6mg × 5 pens · 1.8mg × 5 pens · 3mg × 5 pens |
| Approved medicine using it | Ozempic® · Wegovy® | Saxenda® · Victoza® |
| Availability | In stock | In stock |
| Batch COA | Supplied with order | Supplied with order |
| From | €292.90 | €194.90 |
How they differ
Both are GLP-1 receptor agonists built on the same principle: resist the DPP-4 enzyme that degrades native GLP-1 within minutes. They differ in how far each takes that resistance.
Liraglutide carries a C16 fatty acid chain and holds a half-life around 13 hours, which is why the approved medicines built on it are once-daily. Semaglutide uses a C18 di-acid with an added spacer, pushing albumin binding far higher and the half-life to roughly seven days — the basis for weekly dosing.
For reconstitution work this changes the arithmetic more than the pharmacology: the same target dose spread across seven days rather than one produces very different draw volumes.
At the bench
The half-life gap changes the arithmetic more than the handling. Reaching comparable weekly exposure with a daily compound rather than a weekly one means much smaller individual draws, and small draws are exactly where a narrow barrel earns its place.
What this comparison does not settle
Half-life describes clearance, not effect. Two compounds reaching the same weekly exposure do not necessarily produce the same receptor occupancy over time, and the peak-to-trough profile of a daily agent differs sharply from a weekly one.
Common questions
What is the difference between Semaglutide and Liraglutide?
Semaglutide persists for about a week; liraglutide for about half a day. Two GLP-1 agonists from the same family, separated mainly by half-life.
Is Semaglutide or Liraglutide better?
Neither, and the question does not have a general answer. They are compared here on mechanism rather than merit. Half-life describes clearance, not effect. Two compounds reaching the same weekly exposure do not necessarily produce the same receptor occupancy over time, and the peak-to-trough profile of a daily agent differs sharply from a weekly one.
Which of the two has more published data?
Both. Each is the active compound in an approved medicine, so both have published trial data behind them.
For research use only. Not for human consumption, diagnostic, therapeutic or veterinary use. Brand names are trademarks of their respective owners and are referenced only to identify the active compound — no affiliation or equivalence is claimed.